Mounjaro And Medical Aid In South Africa

Mounjaro is not cheap, and for many South Africans the cost of treatment is the deciding factor in whether to start. Medical aid cover changes that calculation significantly when it applies, but cover is uneven and the criteria vary across schemes and options.

Here is the honest picture, plus what to ask and how to ask it.

The Two Indications, Different Treatment

For type 2 diabetes

Type 2 diabetes is a Prescribed Minimum Benefit (PMB) condition in South Africa, meaning all medical aids are required to cover certain aspects of treatment. The medications covered under PMB for diabetes have historically been older, cheaper options. GLP-1 and GIP/GLP-1 medications like Mounjaro are increasingly being added to scheme formularies but the level of cover varies significantly.

What to expect:

• Cover is more likely on hospital plans or higher options
• Often subject to chronic disease registration
• May require prior authorisation
• May require that older first line medications (metformin) have been tried first
• May be subject to maximum monthly amounts or co-payments

For weight management

This is where cover becomes patchy. Weight management has historically been treated by many schemes as a 'lifestyle' issue rather than treatment for a medical condition. The recent SAHPRA approval for chronic weight management may shift this over time, but as of writing many schemes do not cover weight management medications, or cover them only on premium options with specific criteria.

Where cover does exist for weight management, criteria typically include:

• BMI thresholds (often 30+ or 27+ with comorbidities, matching the SAHPRA indication)
• Documentation of previous weight management efforts
• Engagement with a structured weight management programme
• Cardiovascular or metabolic comorbidities
• Periodic reassessment and demonstrated response

How To Find Out What Your Scheme Covers

The information is not always easy to find on scheme websites because formularies are updated periodically and the policy wording can be opaque. The reliable approach:

1. Call your scheme directly

Ask specifically:

• "Is tirzepatide on your formulary?"
• "For which indications: type 2 diabetes only, or also chronic weight management?"
• "What option does this cover apply on?" (the option you are on matters)
• "What criteria need to be met?"
• "Is prior authorisation required?"
• "Is there a co-payment or maximum monthly limit?"

2. Get it in writing

Ask the consultant to email you the answer or send a written reference. Verbal answers from call centres are not always accurate.

3. Check the formulary document

Most schemes publish their full formulary online. It is dense but searchable. Look for 'tirzepatide' and 'Mounjaro'. Note that PMB and chronic disease formularies are sometimes separate documents.

Major SA Schemes Overview

The landscape is shifting and any specifics here are likely outdated before too long. As a rough orientation at the time of writing:

• Discovery Health. Has historically covered GLP-1 medications for type 2 diabetes under specific conditions on certain plans. Weight management cover is more limited, with engagement in their Vitality programme sometimes required.
• Bonitas. Coverage variable by plan. Diabetes treatment generally covered, weight management depends on option.
• Momentum Health. Coverage varies. Higher options tend to include more.
• Fedhealth. Has historically been one of the more generous schemes on chronic medication.
• GEMS. Public service scheme, follows specific formulary rules. Worth checking directly.
• Bestmed and others. Variable. Check directly.

This list is not comprehensive and is intended only as orientation. The specifics for your situation come from calling your specific scheme.

Making The Case For Cover

If your scheme does not currently cover Mounjaro for your situation but you believe a clinical case can be made, several routes exist:

Specialist motivation

For complex cases, a specialist physician or endocrinologist motivation can sometimes obtain individual cover where the formulary does not include it. This is not common but does happen.

Comorbidity documentation

If you have documented type 2 diabetes, hypertension, sleep apnoea, or other comorbidities, ensuring these are properly recorded with the scheme may shift the cover decision.

Programme participation

Some schemes that do not cover Mounjaro outright will cover it as part of a structured weight management programme they run or endorse.

Appeal

If cover is declined, schemes have formal appeal processes. These work best with strong clinical motivation and documentation.

If Cover Is Not Available

For people paying out of pocket, several practical points:

• Confirm pharmacy pricing before each refill. Different pharmacies have different SEP-aligned pricing and dispensing fees.
• Some online dispensing pharmacies offer slightly different pricing than retail.
• Medical expenses may be partially recoverable through tax depending on your situation. Keep receipts.
• Starting and lower doses are cheaper than higher doses. If you respond well at 5 mg or 10 mg, ongoing costs are lower than at 15 mg.

What Not To Do

Do not buy tirzepatide from overseas sellers or 'compounding' websites to save cost. SAHPRA has issued warnings about substandard and falsified GLP-1 products. The locally distributed Aspen Mounjaro through a SAPC registered pharmacy is the only properly regulated route. Cheaper alternatives outside this chain are not a saving, they are a different category of risk.

The Bigger Conversation

Medical aid coverage for weight management medications is likely to evolve in SA over the coming years. International experience suggests that as the cost-benefit case becomes clearer (these medications reduce downstream costs of diabetes, cardiovascular disease, and joint disease), more schemes add them to formulary. The recent SAHPRA approval for chronic weight management is part of this trajectory.

For now, check directly, plan financially, and discuss alternatives if cost makes Mounjaro impractical for you.